• WHO Recommends Dapivirine Ring as New Women's HIV Prevention Choice

    The World Health Organization recommended IPM's monthly dapivirine ring, the first long-acting HIV prevention product, as part of a comprehensive prevention approach. Read about this milestone and the next steps for the ring.

    Read more

  • What is the Dapivirine Ring?

    Watch this short video to learn about the monthly dapivirine ring, which could one day soon expand women’s choices for HIV prevention.

    Read more

  • Spotlighting Women's Voices

    Women are at the core of everything we do at IPM. To celebrate International Women's Day, read these stories and experiences by women, for women!

    Read more

  • A Milestone for Women’s HIV Prevention

    The European Medicines Agency issued a positive scientific opinion for IPM’s monthly dapivirine vaginal ring for women's HIV risk reduction. Read what this exciting news means for women and the ring.

    Read more

  • A Healthy World Starts with Healthy Women

    Learn why a healthy world starts with healthy, empowered women.

    Read more

What's New

VIDEO: A Long-Acting and Woman-Controlled HIV Prevention Option double_arrow
Dapivirine Vaginal Ring Added to WHO Clinical Guidelines as HIV Prevention Choice for Women double_arrow
IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration double_arrow
Dapivirine ring OLE study results featured in The Lancet HIV double_arrow